Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Kneidinger, A. Nave, G. Kwapiszewska, C. Vogelmeier, W. Seeger, R. Morty (Giessen, Marburg, Germany). Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease?. Eur Respir J 2010; 36: Suppl. 54, 5541

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Erythropoietin dysregulation in chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Mediators of lymphoid neogenesis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Immune modulation of airways diseases Year: 2010 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Emphysema contribution to the progression of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 654s Year: 2006 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 What is new in chronic obstructive pulmonary disease? Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=153 Year: 2007 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation? Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018 Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Inflammation and depression in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 718s Year: 2007 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008